Related Experiment Video
Updated: May 25, 2026
10:25
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
Vigilance-controlled quantified EEG in safety pharmacology
N Dürmüller1, R D Porsolt, R Scherschlicht
1Porsolt and Partners Pharmacology, Boulogne Billancourt, France.
Current Protocols in Pharmacology
|February 2, 2012
Summary
Vigilance-controlled quantified electroencephalography (EEG) serves as a valuable preclinical tool for drug development. Rat EEG reliably predicts human central nervous system drug effects, guiding research direction.
Area of Science:
- Neuroscience
- Pharmacology
- Preclinical drug development
Background:
- Electroencephalography (EEG) is a method to record electrical activity of the brain.
- Quantified EEG (qEEG) analysis provides objective measures of brain activity.
- Vigilance-controlled qEEG incorporates behavioral state into EEG analysis.
Purpose of the Study:
- To evaluate the utility of vigilance-controlled quantified EEG (qEEG) in preclinical drug development.
- To determine if rat EEG can predict human central nervous system (CNS) drug effects.
Main Methods:
- Utilized vigilance-controlled quantified EEG (qEEG) in a rat model.
- Administered psychoactive drugs and convulsants to rats.
- Analyzed EEG responses to assess drug effects.
Main Results:
- Vigilance-controlled qEEG can function as both a safety and a discovery pharmacology procedure.
- Rat EEG responses to CNS drugs are similar to human responses.
- Rat EEG serves as a reliable predictor of human CNS drug effects.
Conclusions:
- Strategic implementation of vigilance-controlled qEEG in preclinical development aids decision-making for future research.
- Rat EEG is a valuable and predictive model for human CNS drug effects.
- This method supports informed progression of drug candidates through the development pipeline.
